Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net Sales	$ 11,667,579	$ 5,732,734
Cost of Goods Sold	7,569,193	4,723,398
Gross Profit	4,098,386	1,009,336
Operating Expenses
Research and development	53,408	310,672
Selling. General and Administrative Expenses	11,341,712	4,011,556
Total Operating Expenses	11,395,120	4,322,228
Operating Loss	(7,296,734)	(3,312,892)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	66,862	0
Forgiveness of paycheck protection program loan	296,827	0
Loss on contingent consideration	(574,000)	0
Other Income	24,871	10,936
Total Other Income (Expense)	(185,440)	10,936
Loss Before Provision (Benefit) for Income Taxes	(7,482,174)	(3,301,956)
Provision (Benefit) from Income Taxes	(91,819)	66,854
Net Loss	(7,390,355)	(3,368,810)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(603,750)	0
Net Loss attributable to common stockholders	$ (7,994,105)	$ (3,368,810)
Basic and Diluted Loss Per Common Share	$ (0.86)	$ (0.59)
Weighted Average Shares Outstanding - basic and diluted	9,273,257	5,733,591